Cara Therapeutics | CARA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alterity Therapeutics Limited AUD 39M 17M 2026-09
Cara Therapeutics USD 30M 336M 2026-03
Cassava Sciences USD 82M 14M 2026-03
Chugai Pharma JPY 12.65T 1.81T 2026-06
Cipla INR 1.18T 194.93B 2026-06
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.29M 475.62M 2026-03
CSL USD 55.89B 20.42B 2025-12
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
J&J USD 611.36B 32.21B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pacira USD 998M 83M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
RedHill Biopharma USD 1000K 4M 2026-09
Supernus Pharmaceuticals USD 2.7B 277M 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12